Device Trial Radar · NCT07287423
LEAP 2 Chronic EFS
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 13, 2025
Primary completion
Jul 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, single-arm, non-randomized, unblinded, chronic feasibility study designed to evaluate the safety and performance of the AVEIR™ Conduction System Pacing (CSP) Leadless Pacemaker system.
Conditions
- Cardiac Pacemaker
- Cardiac Rhythm Disorder
- Bradycardia
Interventions
AVEIR CSP Leadless Pacemaker SystemDevice
Patients will undergo a single or dual-chamber leadless pacemaker system implant wherein an investigational AVEIR CSP leadless pacemaker will be implanted in the right ventricle. Then, a commercial AVEIR AR leadless pacemaker may optionally be co-implanted in the right atrium, if indicated.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Free From AVEIR CSP related Complications at 1-monthTime frame: 1 month
- Average AVEIR CSP LP Pacing Thresholds and Sense Amplitude Measurements at 1-monthTime frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nemocnice Na Homolce
Prague, Czechia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.